New Bio Studio project will develop novel antibody platform to address high unmet needs

BioInnovation Institute (BII), a non-profit institute incubating and accelerating world-class life science research, today announces it has entered into a collaboration with the Technical University of Denmark (DTU) to support a translational research project through its company creation program, Bio Studio.

“Monoclonal antibody treatments are currently costly to the patients and the healthcare system, and they are often inconvenient to administer as they require intravenous or subcutaneous injections. We firmly believe that our monoclonal antibody-based therapies will increase efficacy and safety while reducing the dosing volume and frequency. This will benefit the patient and bring the cost down to a commercially attractive level”

Rikke Christina Nielsen Entrepreneur in Residence